---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-001275"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2026-01-08T23:59:59+00:00"
generated_at: "2026-05-16T11:15:08.307215+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Context Therapeutics files updated corporate presentation; no material new information disclosed

## Summary
- Filing updates corporate presentation for investor meetings; presentation content not included in this 8-K.
- No financial results, pipeline updates, or guidance changes announced.
- Event is a routine FD disclosure; no material impact expected.

## SEC filing metadata
- accession: 0001628280-26-001275
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2026-01-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000162828026001275/0001628280-26-001275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000162828026001275/cntx-20260108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-001275
- JSON: https://secwatch.observer/filing/0001628280-26-001275.json
- Plain text: https://secwatch.observer/filing/0001628280-26-001275.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.